Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in children

被引:42
作者
Kondo, M
Kojima, S
Horibe, K
Kato, K
Matsuyama, T
机构
[1] Okazaki City Hosp, Dept Pediat, Okazaki, Aichi 4448553, Japan
[2] Nagoya Univ, Sch Med, Dept Pediat, Nagoya, Aichi 466, Japan
[3] Nagoya First Hosp, Japanese Red Cross, Childrens Med Ctr, Div Hematol Oncol, Nagoya, Aichi, Japan
关键词
chronic GVHD; stem cell transplantation; risk factor; children;
D O I
10.1038/sj.bmt.1702868
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
We analyzed the incidence and risk factors for chronic graft-versus-host disease (GVHD) in 265 children undergoing allogeneic stem cell transplantation (SCT) who survived longer than 3 months post SCT, Patients transplanted from HLA-mismatched related donors and matched unrelated donors were included. Fifty-five patients developed chronic GVHD between 1 and 25 months after SCT, and the 5-year cumurative incidence of chronic GVHD was 22%. By multivariate analysis, acute GVHD (P = 0.004), malignant disease (P = 0.004), recipient age ((greater than or equal to 10 years) (P = 0.01) and a female donor to male recipient (P = 0.035) were significant risk factors for chronic GVHD. When acute GVHD was excluded from the multivariate analysis, malignant disease (P = 0.002) and older recipient age (P = 0.007) were identified. The incidence of chronic GVHD in this childhood study was lower than that observed in adults, and recipient age was an important factor in childhood SCT, The high incidence associated with malignant disease may be affected by changes in GVHD prophylaxis in order to ensure graft-versus-tumor effects.
引用
收藏
页码:727 / 730
页数:4
相关论文
共 50 条
[41]   Breath analysis in gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation [J].
Hamilton, Betty K. ;
Rybicki, Lisa A. ;
Grove, David ;
Ferraro, Christina ;
Starn, Jamie ;
Hodgeman, Brittany ;
Elberson, Jamie ;
Winslow, Victoria ;
Corrigan, Donna ;
Gerds, Aaron T. ;
Hanna, Rabi ;
Kalaycio, Matt E. ;
Sobecks, Ronald M. ;
Majhail, Navneet S. ;
Dweik, Raed A. .
BLOOD ADVANCES, 2019, 3 (18) :2732-2737
[42]   Chronic Graft-Versus-Host Disease (GVHD) in Children [J].
Baird, Kristin ;
Cooke, Kenneth ;
Schultz, Kirk R. .
PEDIATRIC CLINICS OF NORTH AMERICA, 2010, 57 (01) :297-+
[43]   Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation [J].
Kheav, Vissal David ;
Busson, Marc ;
Scieux, Catherine ;
de Latour, Regis Peffault ;
Maki, Guitta ;
Haas, Philippe ;
Mazeron, Marie-Christine ;
Carmagnat, Maryvonnick ;
Masson, Emeline ;
Xhaard, Alienor ;
Robin, Marie ;
Ribaud, Patricia ;
Dulphy, Nicolas ;
Loiseau, Pascale ;
Charron, Dominique ;
Socie, Gerard ;
Toubert, Antoine ;
Moins-Teisserenc, Helesne .
HAEMATOLOGICA, 2014, 99 (12) :1860-1867
[44]   Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning [J].
Poloni, Antonella ;
Sartini, Davide ;
Emanuelli, Monica ;
Trappolini, Silvia ;
Mancini, Stefania ;
Pozzi, Valentina ;
Costantini, Benedetta ;
Serrani, Federica ;
Berardinelli, Eleonora ;
Renzi, Elisabetta ;
Olivieri, Attilio ;
Leoni, Pietro .
CYTOKINE, 2011, 53 (03) :376-383
[45]   Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study [J].
Itonaga, Hidehiro ;
Iwanaga, Masako ;
Aoki, Kazunari ;
Aoki, Jun ;
Ishiyama, Ken ;
Ishikawa, Takayuki ;
Sakura, Toru ;
Fukuda, Takahiro ;
Najima, Yuho ;
Yujiri, Toshiaki ;
Mori, Takehiko ;
Kurokawa, Mineo ;
Nawa, Yuichiro ;
Uchida, Naoyuki ;
Morishita, Yoshihisa ;
Hashimoto, Hisako ;
Eto, Tetsuya ;
Hirokawa, Makoto ;
Morishima, Yasuo ;
Nagamura-Inoue, Tokiko ;
Atsuta, Yoshiko ;
Miyazaki, Yasushi .
LEUKEMIA RESEARCH, 2016, 41 :48-55
[46]   Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation [J].
Atsuta, Y ;
Suzuki, R ;
Yamamoto, K ;
Terakura, S ;
Iida, H ;
Kohno, A ;
Naoe, T ;
Yano, K ;
Wakita, A ;
Taji, H ;
Hamaguchi, M ;
Kodera, Y ;
Sao, H ;
Morishima, Y ;
Hamajima, N ;
Morishita, Y .
BONE MARROW TRANSPLANTATION, 2006, 37 (03) :289-296
[47]   Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation [J].
Y Atsuta ;
R Suzuki ;
K Yamamoto ;
S Terakura ;
H Iida ;
A Kohno ;
T Naoe ;
K Yano ;
A Wakita ;
H Taji ;
M Hamaguchi ;
Y Kodera ;
H Sao ;
Y Morishima ;
N Hamajima ;
Y Morishita .
Bone Marrow Transplantation, 2006, 37 :289-296
[48]   Marked telomere fluctuation of leukocytes during graft-versus-host disease in allogeneic stem cell transplantation [J].
Sashida, G ;
Ohyashiki, JH ;
Kubota, N ;
Shoji, N ;
Ishii, Y ;
Tauchi, T ;
Kimura, Y ;
Shay, JW ;
Ohyashiki, K .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2005, 16 (05) :883-888
[49]   The use of monoclonal antibodies for the treatment of graft-versus-host disease following allogeneic stem cell transplantation [J].
Busca, Alessandro .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (06) :687-697
[50]   Cutaneous Chronic Graft Versus Host Disease Following Allogeneic Haematopoietic Stem Cell Transplantation in Children: A Retrospective Study [J].
Shreberk-Hassidim, Rony ;
Neumark, Michal ;
Greenberger, Shoshana ;
Goldstein, Gal ;
Hassidim, Ayal ;
Dukler, Yuval ;
Maly, Alexander ;
Stepensky, Polina ;
Molho-Pessach, Vered .
ACTA DERMATO-VENEREOLOGICA, 2018, 98 (02) :206-211